A randomized trial of pamrevlumab in patients with COVID-19 pneumonia

被引：2

作者：

Sgalla, Giacomo ^{[1
]}

Leone, Paolo Maria ^{[1
]}

Gualano, Gina ^{[2
]}

Simonetti, Jacopo ^{[1
]}

Comes, Alessia ^{[1
]}

Verdirosi, Diana ^{[1
]}

Di Gennaro, Francesco ^{[2
]}

Larici, Anna Rita ^{[3
]}

Ianniello, Stefania ^{[4
]}

Cicchetti, Giuseppe ^{[3
]}

Fusco, Nicoletta ^{[4
]}

Pani, Marcello ^{[5
]}

Palmieri, Fabrizio ^{[2
]}

Richeldi, Luca ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, UOC Pneumol, Rome, Italy

[2] Ist Nazl Malattie Infett Lazzaro Spallanzani IRCCS, UOC Malattie Infett Apparat Resp, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia Oncolo, Rome, Italy

[4] Ist Nazl Malattie Infett Lazzaro Spallanzani IRCCS, UOSD Diagnost Immagini nelle Malattie Infett, Rome, Italy

[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, UOC Farm, Rome, Italy

来源：

RESPIROLOGY | 2023年 / 28卷 / 10期

关键词：

COVID-19; interstitial lung disease; lung fibrosis; pulmonary fibrosis;

D O I：

10.1111/resp.14575

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：954 / 957

页数：4

共 50 条

[41] COVID-19 pneumonia
Pfeifer, M.
Hamer, O. W.
GASTROENTEROLOGE, 2020, 15 (06): : 457 - 470
[42] Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial
Munoz-Rivas, N.
Aibar Gallizo, J.
Gabara-Xanco, C.
Trueba-Vicente, A.
Urbelz-Perez, A.
Gomez-Del Oimo, V.
Demelo-Rodriguez, P.
Rivera-Gallego, A.
Bosch-Nicolau, P. A. U.
Nieto Rodriguez, J. A.
Rios-Prego, M.
Madridano-Cobo, O.
Mendez, M.
Hernandez-Rivas, J. A.
Torres-Macho, J.
EUROPEAN HEART JOURNAL, 2022, 43 : 1908 - 1908
[43] Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia
Scott, Hayley
Zahra, Aleena
Fernandes, Rafael
Fries, Bettina C.
Thode, Henry C., Jr.
Singer, Adam J.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 51 : 1 - 5
[44] Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial
Dilokpattanamongkol, Pitchaya
Yan, Chadakan
Jayanama, Kulapong
Ngamjanyaporn, Pintip
Sungkanuparph, Somnuek
Rotjanapan, Porpon
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
[45] Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial
Masaharu Shinkai
Kenji Tsushima
Shingo Tanaka
Eri Hagiwara
Norihito Tarumoto
Ichiro Kawada
Yuji Hirai
Sho Fujiwara
Yuko Komase
Takeshi Saraya
Hidefumi Koh
Naho Kagiyama
Megumi Shimada
Daiki Kanou
Shinichi Antoku
Yujiro Uchida
Yutaka Tokue
Mikio Takamori
Yasuhiro Gon
Kenya Ie
Yoshitaka Yamazaki
Kazumasa Harada
Naoki Miyao
Takashi Naka
Mitsunaga Iwata
Atsushi Nakagawa
Kazutoshi Hiyama
Yoshihiko Ogawa
Masahiro Shinoda
Shinichiro Ota
Takatomo Hirouchi
Jiro Terada
Shuichi Kawano
Takashi Ogura
Tsutomu Sakurai
Yoshihiko Matsumoto
Hiroyuki Kunishima
Osamu Kobayashi
Satoshi Iwata
Infectious Diseases and Therapy, 2021, 10 : 2489 - 2509
[46] Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial
Pitchaya Dilokpattanamongkol
Chadakan Yan
Kulapong Jayanama
Pintip Ngamjanyaporn
Somnuek Sungkanuparph
Porpon Rotjanapan
BMC Complementary Medicine and Therapies, 24
[47] Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial
Wu, Huimin
Daouk, Salim
Kebbe, Jad
Chaudry, Fawad
Harper, Jarrod
Brown, Brent
PLOS ONE, 2022, 17 (10):
[48] Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial
Shinkai, Masaharu
Tsushima, Kenji
Tanaka, Shingo
Hagiwara, Eri
Tarumoto, Norihito
Kawada, Ichiro
Hirai, Yuji
Fujiwara, Sho
Komase, Yuko
Saraya, Takeshi
Koh, Hidefumi
Kagiyama, Naho
Shimada, Megumi
Kanou, Daiki
Antoku, Shinichi
Uchida, Yujiro
Tokue, Yutaka
Takamori, Mikio
Gon, Yasuhiro
Ie, Kenya
Yamazaki, Yoshitaka
Harada, Kazumasa
Miyao, Naoki
Naka, Takashi
Iwata, Mitsunaga
Nakagawa, Atsushi
Hiyama, Kazutoshi
Ogawa, Yoshihiko
Shinoda, Masahiro
Ota, Shinichiro
Hirouchi, Takatomo
Terada, Jiro
Kawano, Shuichi
Ogura, Takashi
Sakurai, Tsutomu
Matsumoto, Yoshihiko
Kunishima, Hiroyuki
Kobayashi, Osamu
Iwata, Satoshi
INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2489 - 2509
[49] Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
Ali, Karim
Azher, Tanweer
Baqi, Mahin
Binnie, Alexandra
Borgia, Sergio
Carrier, Francois M.
Cavayas, Yiorgos Alexandros
Chagnon, Nicolas
Cheng, Matthew P.
Conly, John
Costiniuk, Cecilia
Daley, Peter
Daneman, Nick
Douglas, Josh
Downey, Catarina
Duan, Erick
Duceppe, Emmanuelle
Durand, Madeleine
English, Shane
Farjou, George
Fera, Evradiki
Fontela, Patricia
Fowler, Rob
Fralick, Michael
Geagea, Anna
Grant, Jennifer
Harrison, Luke B.
Havey, Thomas
Hoang, Holly
Kelly, Lauren E.
Keynan, Yoav
Khwaja, Kosar
Klein, Gail
Klein, Marina
Kolan, Christophe
Kronfli, Nadine
Lamontagne, Francois
Lau, Michael
Lee, Todd C.
Lee, Nelson
Lim, Rachel
Longo, Sarah
Lostun, Alexandra
MacIntyre, Erika
Malhame, Isabelle
Mangoff, Kathryn
McGuinty, Marlee
Mergler, Sonya
Munan, Matthew
Murthy, Srinivas
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (07) : E242 - E251
[50] Utilizing the sublingual form of squalene in COVID-19 patients: a randomized clinical trial
Ebrahimi, Mahmoud
Farhadian, Nafiseh
Soflaei, Sara Saffar
Amiri, Alireza
Tanbakuchi, Davoud
Oskooee, Rozita Khatamian
Karimi, Mohammad
SCIENTIFIC REPORTS, 2024, 14 (01)

← 1 2 3 4 5 →